LY4005130治疗成人重度斑秃(脱发)患者的研究
一项2期、随机、多中心、双盲、安慰剂对照概念验证研究,旨在调查LY4005130在成人重度斑秃患者中的疗效和安全性
The purpose of this study is to evaluate how well LY4005130 works in participants with severe alopecia areata (hair loss) when compared with placebo, and how well it's tolerated and what side effects may occur. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
The study drug will be administered intravenously (IV) (into a vein in the arm).
The study will last approximately 48 weeks, including screening.
研究概览
研究类型
注册 (估计的)
阶段
- 阶段2
联系人和位置
学习联系方式
- 姓名:Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
- 电话号码:1-317-615-4559
- 邮箱:LillyTrials@Lilly.com
研究联系人备份
- 姓名:Physicians interested in becoming principal investigators please contact
- 邮箱:clinical_inquiry_hub@lilly.com
学习地点
-
-
-
Beijing、中国、100050
- 招聘中
- Beijing Friendship Hospital Affiliate of Capital University
-
首席研究员:
- Fenglin Zhuo
-
Shanghai、中国、200040
- 招聘中
- Huashan Hospital, Fudan University
-
首席研究员:
- Wenyu Wu
-
Shanghai、中国、200071
- 招聘中
- Shanghai Skin Disease Hospital
-
首席研究员:
- Yuling Shi
-
Tianjin、中国、300052
- 招聘中
- Tianjin Medical University General Hospital
-
首席研究员:
- Huiping Wang
-
-
-
-
-
Kelowna、加拿大、V1Y 5A8
- 招聘中
- Kelowna Health and Memory Centre
-
首席研究员:
- Nicola Gray
-
Newmarket、加拿大、L3Y 5G8
- 招聘中
- Ryan Clinical Research Inc.
-
首席研究员:
- Sanjay Siddha
-
接触:
- 电话号码:905-235-5232
-
Ottawa、加拿大、K1V 1C1
- 招聘中
- Dar Clinical Research - Ottawa - Hunt Club Road
-
首席研究员:
- Reetesh Bose
-
Verdun、加拿大、H4G 2L8
- 招聘中
- SIMa Recherche
-
接触:
- 电话号码:5147308398
-
首席研究员:
- Simon Nigen
-
-
-
-
-
Gdansk、波兰、80-546
- 招聘中
- Centrum Badan Klinicznych PI-House sp. z o.o.
-
接触:
- 电话号码:48513104911
-
首席研究员:
- Aleksandra Okuniewska
-
Krakow、波兰、31-559
- 招聘中
- Diamond Clinic
-
首席研究员:
- Barbara Rewerska
-
接触:
- 电话号码:+ 48 696 049 029
-
Ostrowiec Świętokrzyski、波兰、27-400
- 招聘中
- Dermedic Jacek Zdybski
-
首席研究员:
- Jacek Zdybski
-
接触:
- 电话号码:786643111
-
Wroclaw、波兰、50-414
- 招聘中
- Centrum Medyczne Ginemedica
-
首席研究员:
- Justyna Kwapisz
-
-
-
-
California
-
Fremont、California、美国、94538
- 招聘中
- Center For Dermatology Clinical Research, Inc.
-
首席研究员:
- Sunil Dhawan
-
接触:
- 电话号码:510-797-0140
-
Northridge、California、美国、91325
- 招聘中
- Northridge Clinical Trials
-
首席研究员:
- Navid Ezra
-
接触:
- 电话号码:818-350-7482
-
Santa Clarita、California、美国、91355
- 招聘中
- Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway
-
接触:
- 电话号码:833-525-2872
-
首席研究员:
- Bernard Raskin
-
-
Florida
-
Cutler Bay、Florida、美国、33189
- 招聘中
- Health Clinical Research, LLC
-
首席研究员:
- Soroush Aghigh
-
接触:
- 电话号码:786-280-1977
-
-
Massachusetts
-
Boston、Massachusetts、美国、02115
- 招聘中
- Brigham and Women's Hospital
-
首席研究员:
- Arash Mostaghimi
-
接触:
- 电话号码:617-732-4918
-
-
Michigan
-
Troy、Michigan、美国、48084
- 招聘中
- Revival Research Institute, LLC
-
首席研究员:
- Ali Moiin
-
接触:
- 电话号码:248-590-0298
-
-
New Hampshire
-
Portsmouth、New Hampshire、美国、03801
- 招聘中
- Stracskin
-
首席研究员:
- Abel Jarell
-
接触:
- 电话号码:617-833-9995
-
-
Texas
-
San Antonio、Texas、美国、78235
- 招聘中
- Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue
-
接触:
- 电话号码:210-852-2779
-
首席研究员:
- John Browning
-
-
Utah
-
South Jordan、Utah、美国、84095
- 招聘中
- Jordan Valley Dermatology & Research Center
-
首席研究员:
- Douglass Forsha
-
-
-
-
-
London、英国、E1 1FR
- 招聘中
- Royal London Hospital
-
首席研究员:
- Maria Angeliki Gkini
-
London、英国、SW10 9NH
- 招聘中
- Chelsea and Westminster Hospital NHS Foundation Trust
-
首席研究员:
- Leila Asfour
-
Salford、英国、M6 8HD
- 招聘中
- Salford Royal Hospital
-
首席研究员:
- Matthew Harries
-
-
-
-
-
Rotterdam、荷兰、3015 GD
- 招聘中
- Erasmus Medisch Centrum
-
接触:
- 电话号码:0647074229
-
首席研究员:
- Rick Waalboer-Spuij
-
-
-
-
-
Dongjak-gu、韩国、06973
- 招聘中
- Chung-Ang University Hospital
-
首席研究员:
- Beomjoon Kim
-
Incheon、韩国、22332
- 招聘中
- Inha University Hospital
-
首席研究员:
- Gwang Seong Choi
-
Jeonju、韩国、54907
- 招聘中
- Jeonbuk National University Hospital
-
首席研究员:
- Jin Park
-
Seoul、韩国、03080
- 招聘中
- Seoul National University Hospital
-
首席研究员:
- OHSANG KWON
-
Seoul、韩国、05278
- 招聘中
- Kyung Hee University Hospital at Gangdong
-
首席研究员:
- Bark Lynn Lew
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Have severe Alopecia Areata (AA) that meets all of the following criteria:
- Hair loss encompassing ≥50% and ≤90% of the scalp, as measured by Severity of Alopecia Tool (SALT) score
- The duration of the current episode of severe AA is at least 6 months and does not exceed 4 years
- No significant spontaneous hair regrowth in the investigator's opinion for at least 6 months
- Agree not to use any AA treatments during the study
Exclusion Criteria:
- Primarily "diffuse" type of AA (characterized by diffuse hair shedding)
- Are currently experiencing other forms of alopecia
- Participants who, in the opinion of the investigator, are currently experiencing or have a history of unstable concomitant disease that requires frequent hospitalizations, and/or frequent use of systemic immunosuppressants that may interfere with participation in the study
- Have had any major surgery within 8 weeks prior to screening or will require major surgery during the study
- Have a history or presence of cardiovascular, respiratory, hepatic, gastrointestinal, endocrine, hematological, neurological, or neuropsychiatric disorders or any other serious and/or unstable illness
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较:Placebo
Placebo administered IV |
Administered IV |
|
实验性的:LY4005130
LY4005130 administered intravenously (IV) |
Administered IV |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
达到绝对脱发严重程度工具 (SALT) 分数 ≤ 20 的参与者百分比
大体时间:第24周
|
第24周
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
药代动力学(PK):LY4005130的谷浓度
大体时间:基线至第20周
|
基线至第20周
|
|
|
Pharmacodynamics (PD): Change from Baseline in Gene Expression of Select Genes from Scalp Biopsy
大体时间:Baseline, Week 24
|
Scalp Biopsy |
Baseline, Week 24
|
合作者和调查者
调查人员
- 研究主任:Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)、Eli Lilly and Company
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 27772
- J5D-MC-FPAC (其他标识符:Eli Lilly and Company)
- 2025-524727-41-00 (其他标识符:EU Trial (CTIS) Number)
- 2025 (美国 NIH 拨款/合同)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.
IPD 共享时间框架
Data are available 6 months after the primary publication or approval of the indication studied in the US and European Union (EU), whichever is later. Data will be indefinitely available for requesting.
IPD 共享访问标准
A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.
IPD 共享支持信息类型
- 研究方案
- 树液
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.